ALEXIS HOUSER: Open Payments
NPI 1891442422 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$353 in 11 payments from 7 companies in 2025. Trend: 2023 $138 · 2024 $749 · 2025 $353
Food & beverage: $353
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 1 | $124 |
| Alkermes, Inc. | 4 | $108 |
| ABBVIE INC. | 2 | $44 |
| ACADIA Pharmaceuticals Inc | 1 | $23 |
| Novartis Pharmaceuticals Corporation | 1 | $22 |
| SK Life Science, Inc. | 1 | $18 |
| Janssen Pharmaceuticals, Inc | 1 | $16 |
Products named: Symbravo, ARISTADA, UBRELVY, VIVITROL, DAYBUE, KESIMPTA, INVEGA SUSTENNA.
Industry payments across MO — which companies pay providers there.
